TheraBiogen Inc. TRAB Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
TheraBiogen Inc. TRAB Company Overview 

Stock Message Board http://investorshangout.com/search?q=TRAB&...mp;yt1=Go!

TheraBiogen Inc. TRAB Current Price and Quotes
Last Price 0.0023
Previous Close 0.0034 Open 0.0023
Daily Range 0.0023 - 0.0023 52wk Range 0.015 - 0.0013
Volume 305,000 Dividend N/A
Average Vol (3m) 85,474 Yield N/A
TheraBiogen Inc. TRAB
Company Information

PO Box 296
Manalapan, NJ 07728

Website: http://www.theramaxrelief.com
Phone: 866-284-9561
Email: info@therabiogen.com

TheraBiogen Inc. TRAB
TheraBiogen, Inc. is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market.

TheraBiogen Inc. TRAB
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report May 31, 2012 10-Q
CIK 0001405286
Fiscal Year End 2/28
OTC Marketplace OTC Pink No Information
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Feb 28, 2011
Incorporated In: NV, USA
Year of Inc. 2005
Employees 5 a/o Jun 17, 2011
Company Officers/Contacts

Kelly T. Hickel CEO, CFO, Secretary
Company Directors

Kelly T. Hickel
Company Notes

Formerly=Kushi Resources, Inc. until 3-2010
Service Providers

Auditor/Accountant
Moss, Krusick & Associates, LP
501 S. New York Avenue, Suite 100
Winter Park, FL, 32789
United States

Legal Counsel
Greenbaum, Rowe, Smith & Davis
PO Box 5600
Woodbridge, NJ, 07090
United States

Investor Relations Firm
Not Available

TheraBiogen Inc. TRAB
TRAB Security Details

Share Structure

Market Value1 $165,974 a/o Sep 06, 2013
Shares Outstanding 72,162,810 a/o Jul 23, 2012
Float 19,000,000 a/o Jun 17, 2011
Authorized Shares 150,000,000 a/o Jun 17, 2011
Par Value  No Par Value
Shareholders

Shareholders of Record 170 a/o Jun 15, 2011
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Mar 24, 2010 Dec 15, 2009 Mar 23, 2010
Security Notes

Capital Change=shs increased by 2.6 for 1 split. Ex-date=03/24/2010. Rec date=12/25/2009. Pay date=03/23/2010.
Short Selling Data

Short Interest 0 (-100%)
Jun 28, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



TheraBiogen Inc. TRAB Recent News

TheraBiogen Inc. TRAB Financials
Period Ending Feb 29, 2012 Feb 28, 2011 Feb 28, 2010 Feb 28, 2009
Total Revenue 951 466 - -
Cost of Revenue 782 489 - 2
Gross Profit 169 (22) - (2)
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 15,892 3,675 884 120
Non-Recurring Items - - - -
Other - - - 59
Operating Income (15,724) (3,697) (884) (181)
Income From Continuing Operations

Add'l Income/Expense Items - 2 - (10)
Earnings Before Interest and Tax (15,723) (3,695) (883) (190)
Interest Expense 434 398 62 -
Earnings Before Tax (16,157) (4,093) (946) (190)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (16,157) (4,093) (946) (190)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (16,157) (4,093) (946) (190)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (16,157) (4,093) (946) (190)

TRAB TheraBiogen Inc. Research DD Guide

TRAB TheraBiogen Inc. Stock Message Board http://investorshangout.com/search?q=TRAB&...mp;yt0=Go!
TRAB TheraBiogen Inc. Stock Quote http://www.otcmarkets.com/stock/TRAB/quote
TRAB TheraBiogen Inc. Stock Chart http://www.otcmarkets.com/stock/TRAB/chart
TRAB TheraBiogen Inc. Company Info http://www.otcmarkets.com/stock/TRAB/company-info
TRAB TheraBiogen Inc. Recent News http://www.otcmarkets.com/stock/TRAB/news
TRAB TheraBiogen Inc. Financials http://www.otcmarkets.com/stock/TRAB/financials
TRAB TheraBiogen Inc. Filings and Disclosure http://www.otcmarkets.com/stock/TRAB/filings
TRAB TheraBiogen Inc. Short Sales http://www.otcmarkets.com/stock/TRAB/short-sales
TRAB TheraBiogen Inc. Insider Disclosure http://www.otcmarkets.com/stock/TRAB/insider-transactions
TRAB TheraBiogen Inc. Research Reports http://www.otcmarkets.com/stock/TRAB/research
TRAB TheraBiogen Inc. Summary http://finance.yahoo.com/q?s=TRAB
TRAB TheraBiogen Inc. Historical Prices http://finance.yahoo.com/q/hp?s=TRAB+Historical+Prices
TRAB TheraBiogen Inc. Interactive Chart http://finance.yahoo.com/echarts?s=TRAB
TRAB TheraBiogen Inc. Basic Chart http://finance.yahoo.com/q/bc?s=TRAB+Basic+Chart
TRAB TheraBiogen Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=TRAB+Basic+Tech.+Analysis
TRAB TheraBiogen Inc. Headlines http://finance.yahoo.com/q/h?s=TRAB+Headlines
TRAB TheraBiogen Inc. Press Releases http://finance.yahoo.com/q/p?s=TRAB+Press+Releases
TRAB TheraBiogen Inc. Company Profile http://finance.yahoo.com/q/pr?s=TRAB+Profile
TRAB TheraBiogen Inc. Key Statistics http://finance.yahoo.com/q/ks?s=TRAB+Key+Statistics
TRAB TheraBiogen Inc. Industry http://finance.yahoo.com/q/in?s=TRAB+Industry
TRAB TheraBiogen Inc. Major Holders http://finance.yahoo.com/q/mh?s=TRAB+Major+Holders
TRAB TheraBiogen Inc. Insider Transactions http://finance.yahoo.com/q/it?s=TRAB+Insider+Transactions
TRAB TheraBiogen Inc. Insider Roster http://finance.yahoo.com/q/ir?s=TRAB+Insider+Roster
TRAB TheraBiogen Inc. Income Statement http://finance.yahoo.com/q/is?s=TRAB
TRAB TheraBiogen Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=TRAB
TRAB TheraBiogen Inc. Cash Flow http://finance.yahoo.com/q/cf?s=TRAB+Cash+Flow&annual
TRAB TheraBiogen Inc. Nasdaq http://www.nasdaq.com/symbol/TRAB
TRAB TheraBiogen Inc. Market Watch http://www.marketwatch.com/investing/stock/TRAB
TRAB TheraBiogen Inc. Bloomberg http://www.bloomberg.com/quote/TRAB:US
TRAB TheraBiogen Inc. Morningstar http://quotes.morningstar.com/stock/s?t=TRAB
TRAB TheraBiogen Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=TRAB
TRAB TheraBiogen Inc. Barchart http://www.barchart.com/quotes/stocks/TRAB
TRAB TheraBiogen Inc. OTC Short Report http://otcshortreport.com/index.php?index=TRAB
TRAB TheraBiogen Inc. Investopedia http://www.investopedia.com/markets/stocks/TRAB/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 146

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 177

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 312

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 210

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 145

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 233

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading

Top 5 Most Recently Viewed Articles

West Pharmaceuticals Welcomes Janet Haugen to Its Board

Updated Category News Views 225

West Pharmaceuticals Welcomes a New Board Member West Pharmaceutical Services, Inc. (NYSE: WST), a leader in the field of innovative injectable drug solutions, has announced an exciting change to its leadership. The company has welcomed Janet Haugen as the newest addition to its Board of Directors, bringing the board's total to twelve members. This strategic move is...

Continue Reading
Middlefield Banc Corp Declares Effective Dividend Strategy

Updated Category News Views 142

Middlefield Banc Corp Cash Dividend Announcement Middlefield Banc Corp. (NASDAQ: MBCN) recently revealed an important update about its dividends, a topic that resonates significantly with both current and potential investors. In a recent board meeting, the executives declared a quarterly cash dividend of $0.21 per common share, indicative of the corporation's ongoing...

Continue Reading
JELD-WEN Announces Major Asset Sale to Enhance Growth Strategy

Updated Category News Views 168

JELD-WEN Completes Significant Divestiture for Future Growth JELD-WEN Holding, Inc. (NYSE: JELD) has made a crucial decision regarding its Towanda facility as part of a court-directed divestiture. This strategic shift involves entering into an asset purchase agreement with Woodgrain Inc. for the Towanda business and its assets. The sale amounts to approximately $115...

Continue Reading
Royal Caribbean Group Announces Significant Dividend Increase

Updated Category News Views 134

Royal Caribbean Group Boosts Dividend Significantly Royal Caribbean Group (NYSE: RCL) recently announced an impressive increase in its quarterly dividend, demonstrating the company's ongoing commitment to its shareholders. The Board of Directors has declared a payment of $1.50 per common share, marking a notable 50% boost. Shareholders will see this payment on April 3,...

Continue Reading
Scholarship Opportunity for Aspiring Entrepreneurs Nationwide

Updated Category News Views 161

Andrew Hillman Launches Scholarship for Entrepreneurs Future business leaders across the United States now have a valuable opportunity to secure financial assistance through the Andrew Hillman Scholarship for Entrepreneurs. This esteemed initiative aims to support aspiring entrepreneurs committed to making a mark in the business world. Founded by Andrew Hillman, a...

Continue Reading